Can you provide the last earnings date for MYCRONIC AB?
MYCRONIC AB (1MYCR.MI) last reported earnings on 2/5/2026.
BIT:1MYCR • SE0025158629
Past quarterly earnings results for MYCRONIC AB (1MYCR.MI), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
EPS & Revenue History (in SEK): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | 1.42 | 1.63 | -12.85% | -39.70% | 2.021B | 1.953B | 3.48% | -1.85% |
| Q3 2025 | 1.11 | 1.07 | 3.40% | -51.63% | 1.709B | 1.617B | 5.69% | -3.99% |
| Q2 2025 | 2.28 | 2.31 | -1.09% | 55.10% | 2.066B | 1.931B | 6.99% | 35.30% |
| Q1 2025 | 3.18 | 3.04 | 4.37% | 27.00% | 2.142B | 2.11B | 1.52% | 26.60% |
| Q4 2024 | 2.36 | 1.58 | 48.96% | -9.94% | 2.059B | 1.826B | 12.76% | 4.62% |
| Q3 2024 | 2.30 | 1.87 | 22.62% | 118.57% | 1.78B | 1.608B | 10.70% | 39.72% |
| Q2 2024 | 1.47 | 1.68 | -12.39% | 114.60% | 1.527B | 1.594B | -4.20% | 22.65% |
| Q1 2024 | 2.50 | 2.20 | 13.73% | 228.95% | 1.692B | 1.693B | -0.06% | 38.80% |
| Q4 2023 | 2.62 | 3.47 | -24.60% | 104.30% | 1.968B | 1.827B | 7.72% | 31.46% |
| Q3 2023 | 1.05 | 0.87 | 21.11% | 34.62% | 1.274B | 1.31B | -2.75% | 4.94% |
| Q2 2023 | 0.69 | 0.86 | -20.05% | -23.46% | 1.245B | 1.355B | -8.12% | -2.20% |
| Q1 2023 | 0.76 | 0.83 | -8.58% | -10.06% | 1.219B | 1.264B | -3.56% | 7.40% |
| Q4 2022 | 1.28 | 2.70 | -52.65% | 40.66% | 1.497B | 1.602B | -6.55% | 15.69% |
| Q3 2022 | 0.78 | 0.68 | 14.99% | 90.24% | 1.214B | 1.182B | 2.71% | 23.12% |
| Q2 2022 | 0.90 | 1.05 | -14.40% | -2.72% | 1.273B | 1.311B | -2.90% | 19.64% |
| Q1 2022 | 0.85 | 0.92 | -8.46% | -57.64% | 1.135B | 1.266B | -10.35% | -12.08% |
| Q4 2021 | 0.91 | 0.77 | 18.17% | 1.11% | 1.294B | 1.198B | 8.01% | 30.31% |
| Q3 2021 | 0.41 | 0.82 | -50.07% | -69.74% | 986M | 1.075B | -8.28% | -7.68% |
| Q2 2021 | 0.92 | 0.95 | -3.01% | -15.60% | 1.064B | 1.068B | -0.37% | -2.03% |
| Q1 2021 | 2.00 | 1.54 | 29.24% | 897.50% | 1.291B | 1.192B | 8.31% | 75.41% |
| Q4 2020 | 0.90 | 0.97 | -7.28% | - | 993M | 1.083B | -8.31% | - |
| Q3 2020 | 1.36 | 1.14 | 18.88% | - | 1.068B | 1.091B | -2.11% | - |
| Q2 2020 | 1.09 | 0.23 | 364.62% | - | 1.086B | 846.23M | 28.33% | - |
| Q1 2020 | 0.20 | 0.03 | 488.12% | - | 736M | 685M | 7.45% | - |
Notes
MYCRONIC AB (1MYCR.MI) last reported earnings on 2/5/2026.
MYCRONIC AB (1MYCR.MI) missed EPS estimates and beat revenue estimates in the most recent quarter.
In the last 4 quarters, MYCRONIC AB (1MYCR.MI) has beaten EPS estimates in 2 out of 4 releases.